A venous malformation is an abnormal cluster of veins that forms before birth and grows proportionally with the body throughout life. Unlike hemangiomas and other vascular tumors that appear, grow rapidly, and often shrink on their own, venous malformations are permanent structural defects in the vein walls. They affect roughly 0.06% of the population, making them the most common type of vascular malformation, though they still qualify as a rare condition.
How Venous Malformations Form
Venous malformations develop because of genetic mutations that disrupt how the cells lining blood vessels grow and organize. These aren’t inherited in the traditional sense for most people. The vast majority arise from spontaneous mutations that occur during fetal development in a single cell, which then multiplies into a patch of abnormal tissue. The resulting veins have walls that are too thin, lack the normal muscular support layer, and form irregular, dilated channels where blood pools instead of flowing efficiently.
Two genes account for most cases. Mutations in a gene called TEK (which makes a protein called TIE2) are responsible for about 60% of sporadic, single-site venous malformations. A second gene, PIK3CA, causes roughly 54% of the cases where no TEK mutation is found. Both genes are involved in signaling pathways that control how blood vessel cells grow and survive. When these pathways become overactive due to the mutation, the result is the disorganized, ballooning vein structures characteristic of the condition.
In rare cases, venous malformations do run in families. These inherited forms are also linked to TEK mutations, but they tend to produce multiple lesions rather than a single one.
What Venous Malformations Look and Feel Like
The appearance and symptoms depend heavily on where the malformation is located and how large it is. On or near the skin surface, venous malformations typically appear as a soft, compressible, bluish mass. They feel spongy to the touch and often swell when the affected area is below the level of the heart, during physical exertion, or when you bear down. Raising the area above your heart usually makes the swelling decrease.
Pain is one of the most common complaints. The sluggish blood flow inside the enlarged channels causes small clots to form, a process called phlebitic episodes. These episodes produce localized pain, tenderness, and swelling that can come and go over weeks. Some people experience chronic, daily aching in the affected area. Over time, the slow blood flow can also lead to hard calcium deposits called phleboliths forming inside the malformation, which are sometimes palpable as small firm lumps.
Location shapes the specific problems a venous malformation causes. In the head and neck, they can create visible bulging, distort facial features, or interfere with breathing and swallowing. In limbs, they may cause the affected arm or leg to grow longer or larger than the other side, particularly when the malformation is extensive. Deep venous malformations in muscles or joints can limit range of motion and cause pain with activity. Some malformations involve internal organs and produce symptoms related to that organ’s function.
A Clotting Problem Unique to Venous Malformations
About 40% of people with venous malformations develop a condition called localized intravascular coagulopathy. Blood pooling in the abnormal channels triggers a low-grade, chronic clotting process confined to the malformation itself. The body responds by breaking down those clots, which releases a protein fragment called D-dimer into the bloodstream.
Elevated D-dimer levels are so specific to venous malformations (96.5% specificity in one study) that a simple blood test can help confirm the diagnosis and distinguish them from other types of vascular malformations, like lymphatic malformations, which don’t cause this clotting pattern. Larger malformations and those with palpable phleboliths are more likely to have elevated D-dimer levels. In severe cases, this ongoing clotting activity can deplete clotting factors throughout the body, which becomes especially important to manage before any planned surgery or procedure.
How Venous Malformations Are Diagnosed
Doctors can often suspect a venous malformation based on physical examination alone, especially when the classic soft, blue, compressible mass is visible. But imaging is essential to confirm the diagnosis, map the full extent of the malformation, and plan treatment.
MRI is the gold standard. Venous malformations produce a very characteristic bright signal on certain MRI sequences (T2-weighted and fat-suppressed images), which makes them stand out clearly against surrounding muscle, fat, and bone. This brightness reflects the slow-moving blood pooled inside the channels. On other MRI sequences, the malformation appears dark. This combination of signals is highly recognizable and helps distinguish venous malformations from tumors or other vascular anomalies. MRI also reveals how deep the malformation extends and which surrounding structures are involved.
Ultrasound serves as a useful first-line tool, particularly in children or when a quick assessment is needed. It can show the dilated vessels and sometimes detect phleboliths within them. However, it doesn’t map the full depth and extent of a lesion as well as MRI does, so it’s typically used as a complement rather than a replacement.
Treatment With Sclerotherapy
The most common treatment for venous malformations is sclerotherapy, a minimally invasive procedure where a chemical agent is injected directly into the malformation under image guidance. The agent damages the inner lining of the abnormal veins, causing them to scar shut and shrink over time. Multiple sessions are usually needed, spaced weeks to months apart.
Several different agents are used, and the choice depends on the malformation’s size, depth, and location. Ethanol (medical-grade alcohol) is one of the most potent options, with patient satisfaction rates around 96% and quality-of-life improvements in roughly 90% of treated patients. However, it carries the highest risk of side effects, including skin damage if it leaks outside the vessels and, rarely, serious complications affecting the heart and lungs. It’s generally reserved for deeper malformations where the skin is not at risk.
For malformations closer to the skin surface, milder agents are preferred. These have a lower complete cure rate (around 55% for some agents compared to roughly 59% for ethanol) but also carry fewer risks. Side effects with milder agents are typically limited to temporary pain, swelling, and bruising. A meta-analysis of sclerotherapy for head and neck venous malformations found that overall, the procedure achieves a complete response in roughly half to four-fifths of patients depending on the agent used, with an additional 16 to 35% experiencing partial improvement. Only a small percentage see no benefit at all.
Medications for Complex Cases
For venous malformations that are too large or too widespread for sclerotherapy alone, an oral medication that suppresses a cell growth pathway (an mTOR inhibitor) has become an important option. In a clinical study of patients with complicated vascular anomalies, 85% showed a partial response after 12 months of treatment, with improvements in both function and lesion size on imaging. No patients achieved complete resolution, but the majority experienced meaningful reductions in pain, swelling, and functional limitations.
This medication works by dialing down the overactive growth signals in the malformation’s cells. It requires regular blood monitoring because it suppresses the immune system and can affect blood cell counts. In the same study, 27% of patients experienced blood-related side effects significant enough to require dose adjustments, though no deaths from treatment toxicity occurred. This approach is typically used for malformations that cause significant symptoms and can’t be adequately managed with procedures alone.
When Surgery Is Considered
Surgical removal is an option when the malformation is well-defined enough to be taken out completely, or when the primary goal is reducing the bulk of a large lesion that distorts appearance or compresses important structures. Surgery can achieve what sclerotherapy cannot: a meaningful reduction in the physical volume of the malformation. The tradeoff is that it’s more invasive, leaves scars, and carries a higher risk of bleeding during the procedure.
In practice, many patients benefit from a combination approach. Sclerotherapy may be performed first to shrink the malformation and reduce blood flow within it, making subsequent surgery safer and more effective. For malformations near critical structures like nerves or airways in the head and neck, sclerotherapy alone is often preferred to avoid the risks of surgical complications in those sensitive areas.
Because venous malformations are present from birth and grow with the body, treatment is focused on managing symptoms and preventing complications rather than achieving a permanent cure. Recurrence or gradual re-expansion after treatment is common, and many people require periodic retreatment throughout their lives.